Pre-diabetes can and does cause neuropathy, and it appears to do so more often than most people realize. A systematic review of 29 studies found that the majority reported neuropathy rates of 10% or higher among people with pre-diabetes, with estimates ranging widely from 2% to 77% depending on how neuropathy was measured and which populations were studied. The nerve damage tends to look different from the neuropathy seen in full-blown diabetes, primarily targeting the smallest sensory nerve fibers rather than the large ones that control muscle strength and reflexes. Understanding how this happens requires looking beyond blood sugar alone, because the mechanisms involve a tangle of metabolic insults that are already underway before anyone receives a diabetes diagnosis.
How Common Is Neuropathy in Pre-diabetes
The short version is that neuropathy in pre-diabetes is far more common than the general public or even many physicians appreciate. One well-known study that classified participants by glucose tolerance testing found an age-adjusted neuropathy rate of about 11% in people with impaired glucose tolerance, compared with roughly 4% in people with normal blood sugar and 26% in those with diabetes.1PubMed Central. Peripheral neuropathy in prediabetes and the metabolic syndrome That 11% figure is not a fringe finding. A systematic review pooling data from 29 studies confirmed that most research groups reported neuropathy rates at or above 10% in pre-diabetic populations, though individual estimates varied enormously depending on the diagnostic tools used and whether the study relied on symptoms, clinical exams, or nerve conduction testing.2BMJ Open Diabetes Research & Care. Prevalence of peripheral neuropathy in pre-diabetes: a systematic review
That wide range deserves a bit of explanation. When researchers use nerve conduction studies, which measure how fast electrical signals travel along larger nerves, they sometimes miss the earliest damage because pre-diabetic neuropathy tends to start in the smallest fibers that those tests do not capture well. One study of patients with impaired glucose tolerance who underwent nerve conduction testing found neuropathy in about 43% of participants, with sensory neuropathy being the most frequent type.3International Journal of Research in Medical Sciences. A study of prevalence of peripheral neuropathy in patients with impaired glucose tolerance The takeaway is that the prevalence depends heavily on how hard you look, and many cases are subclinical, meaning the person has measurable nerve changes but has not yet noticed symptoms.
What Pre-diabetic Neuropathy Feels Like
If you have neuropathy from pre-diabetes, you are most likely to notice it in your feet first. The classic symptoms are burning, tingling, or a pins-and-needles sensation, sometimes accompanied by a vague numbness. Pain can be worse at night. The pattern is typically described as “stocking-and-glove,” meaning it starts in the toes and feet and can gradually spread upward, sometimes eventually reaching the hands.
What distinguishes pre-diabetic neuropathy from the neuropathy of established diabetes is the type of nerve fiber involved. Research consistently shows that the earliest damage targets small nerve fibers, the thin unmyelinated and lightly myelinated fibers responsible for pain, temperature sensation, and some autonomic functions like sweating.4Nature Reviews Endocrinology. Neuropathy in prediabetes: does the clock start ticking early? Large-fiber damage, which causes problems with balance, vibration sense, and muscle weakness, tends to come later and is more characteristic of longstanding diabetes. One study directly comparing people with pre-diabetes and early diabetes against healthy controls found that subclinical small-fiber involvement, measured by counting nerve fiber endings in skin biopsies, was significantly more common in both groups than in controls.5PubMed. Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres
Beyond the feet, pre-diabetes can also affect the autonomic nervous system, the network that controls involuntary functions. People with impaired glucose tolerance show higher rates of autonomic symptoms, including abnormal sweating patterns, problems with blood-vessel dilation in the skin, and changes in heart-rate variability.6Autonomic Neuroscience. Is there cardiac autonomic neuropathy in prediabetes? These autonomic findings are often overlooked because they do not produce the dramatic pain that sensory neuropathy does, but they can contribute to dizziness on standing, digestive irregularity, and exercise intolerance.
How Blood Sugar Damages Nerves Before Diabetes
The most intuitive explanation for nerve damage in pre-diabetes involves blood sugar itself. Even the moderate, repeated glucose spikes that characterize impaired glucose tolerance are enough to set off a chain of harmful chemical reactions inside nerve cells. One of the best-studied pathways involves advanced glycation end products, or AGEs. These are molecules formed when sugars attach to proteins or fats in a haphazard, non-enzymatic way. Once formed, AGEs alter the structure and function of the proteins they cling to, and they also activate receptors on cell surfaces that trigger inflammation and the production of damaging free radicals.7PubMed Central. Advanced glycation end products and diabetic complications
In nerve tissue specifically, AGEs bind to receptors found on sensory neurons and the support cells that insulate nerve fibers. This binding sets off a self-reinforcing loop: the activated receptor triggers inflammatory signaling molecules, which in turn ramp up production of more of the receptor itself, amplifying the damage. Rodent studies have confirmed that animals lacking this receptor are protected from both the electrical and structural nerve deficits that normally accompany high blood sugar. Human nerve biopsies from people with diabetes also show elevated levels of both AGEs and their receptors.8PubMed Central. The Role of Advanced Glycation Endproducts and Glyoxalase I in Diabetic Peripheral Sensory Neuropathy – Section: RAGE
Running alongside the AGE pathway is oxidative stress, a state in which nerve cells accumulate reactive oxygen species faster than their antioxidant defenses can neutralize them. Various metabolic disturbances in pre-diabetes converge on this single outcome. The excess glucose feeds into biochemical pathways that crank out free radicals, while at the same time the cells’ ability to repair the resulting damage is diminished. Enhanced oxidative stress is now widely considered a common initiator that links multiple metabolic defects to nerve injury.9PubMed Central. Understanding Diabetic Neuropathy: Focus on Oxidative Stress
Why It Is Not Just About Sugar
One of the most important insights from the past decade of research is that blood sugar is not the whole story. Many people with pre-diabetic neuropathy have relatively modest glucose elevations, and treating the glucose alone does not always halt the nerve damage. The metabolic syndrome, that cluster of conditions including abdominal obesity, high triglycerides, low HDL cholesterol, high blood pressure, and elevated fasting glucose, appears to contribute independently to neuropathy risk. Dyslipidemia in particular has emerged as a significant player.
Laboratory studies have shown that elevated free fatty acids, especially saturated fats, are directly toxic to nerve cells. When researchers exposed human nerve-support cells to fatty-acid concentrations typical of people with metabolic syndrome, total superoxide production jumped substantially, and the activity of an enzyme responsible for generating reactive oxygen species more than doubled.10PubMed Central. Triglyceride, NEFA, and prediabetic neuropathy: Role for oxidative-nitrosative stress In animal models, a high-fat diet caused long-chain fatty acids from the diet to be incorporated into nerve tissue, where they disrupted the energy-producing machinery of nerve cells and contributed to nerve injury.11Frontiers in Physiology. A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy
This helps explain a puzzle that clinicians have long noticed: some people with pre-diabetes develop neuropathy while others with identical glucose levels do not. The answer often lies in their lipid profiles and overall metabolic health. Clinical and preclinical studies now consistently implicate abnormal lipid levels as a strong risk factor for neuropathy in both pre-diabetes and type 2 diabetes, with saturated and unsaturated fatty acids having very different effects on nerve function.12PubMed Central. A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes
Mitochondrial Damage and Energy Failure in Nerve Cells
Peripheral nerves are extraordinarily long cells. A sensory neuron running from the spinal cord to the tip of a toe can stretch well over a meter, and keeping such a long axon alive requires a tremendous energy supply. Mitochondria, the energy-generating structures inside cells, are shuttled up and down the axon to meet local energy demands. When those mitochondria start to malfunction, the nerve starves from the ends inward, which is why symptoms typically appear in the toes and feet first.
Elevated levels of saturated fatty acids associated with the typical pre-diabetic metabolic profile impair mitochondrial dynamics in sensory neurons. The mitochondria lose their electrical charge, their energy output drops, and their transport along the axon slows down. The resulting energy deficit causes the nerve endings to retract and eventually die. Interestingly, monounsaturated fatty acids appear to have the opposite effect, restoring nerve and mitochondrial function in experimental settings.13PubMed Central. Disorders of mitochondrial dynamics in peripheral neuropathy: Clues from hereditary neuropathy and diabetes This finding has practical implications for dietary choices, though it remains to be confirmed in large human trials.
The Role of Inflammation
Chronic low-grade inflammation is increasingly recognized as a key element in the development of neuropathy, and the inflammatory state begins before diabetes is formally diagnosed. In animal models of metabolic syndrome, elevated levels of pro-inflammatory signaling molecules including TNF-alpha, IL-1-beta, and IL-6 were detected not just in the bloodstream but directly within the nerve tissue itself. At the same time, levels of IL-10, an anti-inflammatory molecule, were reduced both in the blood and in nerve cells.14PLOS ONE. Cytokine-mediated inflammation mediates painful neuropathy from metabolic syndrome This creates a double hit: more inflammatory signals attacking the nerves and fewer protective signals to counterbalance them.
Human studies reinforce this picture. Research has shown that the inflammatory process appears to start in the pre-clinical stages of glucose dysregulation, sometimes well before pre-diabetes is detected. The higher neuropathy frequency in patients with pre-diabetes suggests a possible causal role, though isolating inflammation from the other metabolic insults happening simultaneously remains a challenge.15Clinical Neurology and Neurosurgery. Inflammation role in sensory neuropathy in Chinese patients with diabetes/prediabetes Researchers have identified a broad spectrum of inflammatory biomarkers including various interleukins, chemokines, and immune receptors as potential markers for neuropathy in people with both pre-diabetes and diabetes.16Metabolism Open. The role of novel inflammation-associated biomarkers in diabetic peripheral neuropathy
Insulin Itself May Be Part of the Problem
Another piece of the puzzle is insulin signaling. Neurons in the peripheral nervous system have insulin receptors, and insulin appears to play a direct role in keeping those neurons healthy, beyond just controlling blood sugar. In pre-diabetes, insulin resistance means that even though insulin levels in the blood may be normal or elevated, the signal is not getting through to the cells that need it. The loss of normal insulin signaling in neurons may impair glucose metabolism within the nerve, disrupt neurotransmitter regulation, compromise mitochondrial function, and reduce the nerve’s ability to regenerate after injury.17Frontiers in Neuroscience. A Role for Insulin in Diabetic Neuropathy
Research in animal models has shown that delivering insulin directly to neurons can reverse some features of neuropathy, which suggests that the problem is not simply about glucose toxicity but also about the loss of insulin’s protective effects on nerve tissue.18Diabetes. Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy This creates a layered picture: high glucose damages nerves through the AGE and oxidative stress pathways, while simultaneously the impaired insulin signaling leaves nerves less able to repair that damage. The two processes are not independent but interconnected.
Blood Supply to the Nerves
Peripheral nerves depend on tiny blood vessels, the endoneurial capillaries, for oxygen and nutrients. In people with diabetes and pre-diabetes, these small vessels undergo structural changes early in the disease process. The walls of the capillaries thicken, and the arterioles that feed nerve tissue lose their ability to dilate properly. This impaired blood-vessel relaxation appears before nerve conduction velocity drops, suggesting that the vascular damage precedes and may contribute to the nerve damage rather than simply coinciding with it.19Signal Transduction and Targeted Therapy. Diabetic neuropathy: cutting-edge research and future directions – Section: Microvascular contributions
The result is a form of nerve ischemia: the nerve tissue is not getting enough blood flow, and the reduced oxygen delivery compounds the metabolic damage already being caused by glucose, lipids, and inflammation. The body attempts to compensate by growing more capillaries around the nerve, but the new vessels have the same structural defects, so the increased density does not translate into better perfusion.
Detecting Neuropathy Before Symptoms Appear
One of the most frustrating aspects of pre-diabetic neuropathy is that standard nerve conduction studies, the traditional workhorse of neuropathy diagnosis, often come back normal in the early stages. This makes sense given what we know about the type of fibers affected: small fibers do not generate the electrical signals that nerve conduction studies measure. Several newer approaches have proven more sensitive.
Skin biopsy, which directly counts the tiny nerve fiber endings in a small punch of skin from the leg, is considered the gold standard for small-fiber neuropathy diagnosis. One study found that skin-biopsy nerve-fiber density was already significantly reduced in both early diabetes and pre-diabetes compared with healthy controls.5PubMed. Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres However, findings are not always consistent across studies. A separate investigation found no significant difference in nerve-fiber density between people with pre-diabetes and those with normal glucose metabolism, though people with established diabetes did have lower counts.20PubMed. Prediabetes, diabetes, metabolic syndrome, and small fiber neuropathy This discrepancy likely reflects differences in patient selection and in how pre-diabetes was defined across studies.
A completely non-invasive alternative involves imaging the cornea of the eye using a specialized microscope. The cornea is densely packed with small nerve fibers, and researchers have found that both nerve fiber length and nerve fiber density in the cornea are significantly reduced in people with pre-diabetes compared with healthy controls.21PubMed Central. Alterations in Corneal Nerve Structure and Function in Prediabetes A large population-based study went further, demonstrating that corneal nerve degeneration is a continuous process that worsens linearly as glucose metabolism deteriorates, starting well before the threshold for a diabetes diagnosis is crossed.22PubMed Central. (Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study This technique is still largely a research tool, but it holds promise for catching nerve damage early in routine clinical settings.
What Happens Over Time Without Intervention
Pre-diabetes is not a static condition. It is a transitional state, and whether someone progresses to diabetes, stays in the pre-diabetic range, or reverts to normal glucose tolerance matters enormously for their nerves. Follow-up data from one cohort found that the neuropathy rate was highest, around 50%, in people who progressed from pre-diabetes to diabetes over a three-year period. Those who progressed from normal glucose tolerance to pre-diabetes also had high neuropathy rates, close to 49%. People who maintained normal blood sugar had a substantially lower rate of about 29%.1PubMed Central. Peripheral neuropathy in prediabetes and the metabolic syndrome
These numbers send a clear message: progression matters, and the transition from normal to abnormal glucose metabolism appears to be a particularly vulnerable window for the nerves. They also suggest that early intervention, before someone crosses the diabetes threshold, has a realistic chance of protecting nerve function.
Can the Damage Be Reversed
This is the question most people with pre-diabetic neuropathy want answered, and the honest answer is that the evidence is encouraging but still limited. No large randomized trials have specifically tested treatments for pre-diabetic neuropathy. Most pharmacological management currently focuses on preventing progression to type 2 diabetes rather than directly targeting early nerve damage. Emerging drug approaches being investigated include blood-pressure-pathway medications, newer diabetes drugs, mitochondria-targeted antioxidants, and gene-based therapies, but most of this work remains in early stages.23PubMed. Pharmacologic strategies in prediabetic neuropathy
Lifestyle changes are where the most practical evidence exists today. Diet and exercise interventions that produce weight loss and improve metabolic syndrome components have shown benefit in small studies. One particularly intriguing animal experiment found that a ketogenic diet not only prevented the development of pain sensitivity caused by a high-fat diet but also promoted the regrowth of nerve-fiber endings in the skin. When used as an intervention after damage had already occurred, the ketogenic diet reversed the pain sensitivity and increased nerve-fiber density even though it did not fully reverse the metabolic abnormalities.24ScienceDirect. A ketogenic diet reduces metabolic syndrome-induced allodynia and promotes peripheral nerve growth in mice This is a mouse study and should be interpreted cautiously, but it aligns with the broader understanding that dietary fat composition matters for nerve health and that some nerve damage may be reversible if the metabolic environment improves.
The practical strategy for anyone with pre-diabetes and neuropathy symptoms is to address all the metabolic syndrome components, not just glucose. Weight loss, regular physical activity, improved dietary fat quality, and blood-pressure and lipid management all have plausible mechanisms of benefit for nerve protection, even if the large definitive trials have not yet been done.
Genetic Vulnerability to Neuropathic Pain
Not everyone with the same metabolic profile develops the same degree of nerve pain, and genetics may be part of the reason. A large genome-wide association study identified a genetic variant at a specific chromosomal location that was associated with susceptibility to neuropathic pain. The nearest gene to this variant encodes a mitochondrial protein involved in energy production and calcium balance, which fits neatly with the known role of mitochondrial dysfunction in neuropathy.25JAMA Network Open. Association of Genetic Variant at Chromosome 12q23.1 With Neuropathic Pain Susceptibility While this finding does not change clinical management today, it suggests that some people are biologically primed to develop more pain from the same degree of nerve damage, and it points toward potential future targets for treatment.
The broader lesson is that pre-diabetic neuropathy is not a single disease with a single cause. It is the product of several overlapping metabolic insults, glucose toxicity, lipid-driven damage, inflammation, impaired insulin signaling, and vascular changes, acting on a nervous system whose vulnerability varies from person to person. This complexity is exactly why it has been underdiagnosed and undertreated: there is no single blood test or nerve test that captures the full picture, and there is no single drug that addresses all the contributing pathways at once.